Chromosome aberrations in renal tumors detected by fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 99, Issue 1, 1997, Pages 38-44

  Wada, Yukihiro ^a   Yokogi, Hiroyuki ^a   Moriyama Gonda, Nobuko ^a   Shigeno, Kazushi ^a   Shiina, Hiroaki ^a   Igawa, Mikio ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOIDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MONOSOMY; PRIORITY JOURNAL; TETRASOMY; TRISOMY;

ADULT; AGED; ANEUPLOIDY; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TRISOMY;

EID: 0030728425     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00204-5     Document Type: Article

References (27)

1. Zhao WP, Gnarra JR, Liu S, Knutsen T, Linehan WM, WhangPeng J (1995): Renal cell carcinoma. Cancer Genet Cytogenet 82:128-139.
2. Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jager U, Heinz R, Lechner K, Ludwig H, Huber H (1995): Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res 55:3854-3859.
3. Gomyo Y, Andachi H, Nagao K, Ikeguchi M, Ito H (1995): Interphase cytogenetics of gastric carcinoma: Fluorescence in situ hybridization (FISH) applied to cells obtained from formalin-fixed paraffin-embedded tissues. Pathology Intl 45: 227-232.
4. Shackney SE, Singh SG, Yakulis R, Smith CA, Pollice AA, Petruolo S, Waggoner A, Hartsock RJ (1995): Aneuploidy in breast cancer: A fluorescence in situ hybridization study. Cytometry 22:282-291.
5. Hopman AHN, Moesker O, Smeets AWGB, Pauwels RPE, Vooijs GP, Ramaekers FCS (1991): Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 51:644-651.
6. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH (1995): Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249-254.
7. Beck JML, Hopman AHN, Feitz WFJ, Schalken J, Schaafsma HE, Van de Kaa A, Ramaekers FCS, Hanselaar AGJM, Wilde PGM (1995): Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics. J Pathol 176:123-135.
8. Decker HJH, Klauck SM, Lawrence JB, McNeil J, Smith D, Gemmill RM, Sandberg AA, Neumann HHP, Simon B, Green J, Seizinger BR (1994): Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau Syndrome. Cancer Genet Cytogenet 77:1-13.
9. Grollino MG, Cavallo D, Silverio FD, Rocchi M, Vita RD (1993): Interphase cytogenetics and flow cytometry analyses of renal tumours. Anticancer Res 13:2239-2244.
10. Hermanek P, Scheibe O, Spiessl B, Wagner G (1987): TNM Klassification maligner Tumoren, UICC. Springer-Verlag, New York.
11. Mostofi FK (1981): Histological typing of the kidney tumors. World Health Organization, Geneva.
12. Pinkel D, Straume T, Gray JW (1986): Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci 83:2934-2938.
13. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi O (1994): Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145:624-630.
14. Hopman AHN, Poddighe PJ, Smeets AWGB, Moesker O, Beck JLM, Vooijs GP, Ramaekers FCS (1989): Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J Pathol 135:1105-1117.
15. Schutte B, Reynders MMJ, Bosman FT, Blijham GH (1985): Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6:26-30.
16. Vindelov LL (1977): Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and staining of nuclei. Virchows Arch Cell Path 24:277.
17. Chin L, Pontes E, Frankfurt S (1985): Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J Urol 133:582-585.
18. Currin S, Lee S, Walthers P (1990): Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma; does ploidy status enhance prognostic stratification over stage alone. J Urol 143:458-462.
19. Kloppel G, Knofel T, Baisch H, Otto U (1986): Prognosis of renal cell carcinoma related to nuclear grade, DNA content and Robson stage. Eur Urol 12:426-431.
20. Ljungberg B, Stenling R, Ross G (1986): Prognostic value of deoxyribonucleic acid content in metastatic renal cell carcinoma. J Urol 136:801-804.
21. Elfving P, Cigudosa JC, Lundgren R, Limon J, Mandahl N, Kristoffersson U, Heim S, Mitelman F (1990): Trisomy 7, Trisomy 10 and loss of the Y chromosome in short-term cultures of normal kidney tissue. Cytogenet Cell Genet 53:123-125.
22. Emanuel A, Szucs, Weier H-UG, Kovacs G (1992): Clonal aberrations of chromosome X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosom Cancer 4:75-77.
23. Weaver DJ, Michalski K. Miles J (1988): Cytogenetic analysis in renal cell carcinoma: Correlation with tumor aggressiveness. Cancer Res 48:2897-2899.
24. Meloni AM, Bridge J, Sandberg AA (1992): Reviews on chromosome studies in urological tumors. 1. Renal tumors. J Urol 148:253-265.
25. Kovacs G, Wilkens L, Papp T, DeRiese W (1989): Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst 81:527-530.
26. Psihramis KE, Althausen AF, Yosida MA, Prout GR Jr, Sandberg AA (1986): Chromosome anomalies suggestive of malignant transformation in bilateral renal oncocytoma. J Urol 136:892-895.
27. Kovacs G, Szucs S, Eichner W, Maschek H, Wahnschaffe U, Deriese W (1987): Renal oncocytoma: A cytogenetic and morphologic study. Cancer 59:2071-2077.